Locations:

Cancer

June 5, 2017/Cancer/Research

Study Suggests Some Small Cell Lung Cancer Patients Benefit from Immune Checkpoint Inhibitor

Pembrolizumab stabilizes cancer in some patients

June 5, 2017/Cancer/Research

Trial Finds Maximum Tolerable Dose for Combination Therapy for Metastatic Renal Cell Carcinoma Patients

Axitinib and crizotinib stabilized disease in most

June 4, 2017/Cancer/Research

Maximum Tolerable Doses for Adding Cell Checkpoint Inhibitor to Standard of Care for Glioblastoma Patients

Inhibitor stops DNA repair of cancer cells

June 3, 2017/Cancer/Research

A Novel Approach: Aggressive Chemotherapy Regimen Before Surgery in Resectable Pancreatic Adenocarcinoma

May increase some pancreatic cancer survival rates

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

15-RHE-1651-Chatterjee-Hero-Image-690x380pxl

May 25, 2017/Cancer

Systemic Sclerosis and Malignancy

Analysis of Ssc-breast cancer relationship

May 23, 2017/Cancer/Research

A New Strategy for Cancer Treatments

Moving from whack-a-mole to chess

May 9, 2017/Cancer

Rectal Cancer Discoveries Show Promise for Predicting Neoadjuvant Responders

Study results presented at DDW 2017

May 8, 2017/Cancer/Research

Promising New Combination Therapy for Advanced, HER2+ Breast Cancer Shown Safe and Effective

Neratinib and trastuzumab emtansine (T-DM1) combination potent and well tolerated

April 5, 2017/Cancer/Radiation Oncology

eDosimetry Consult Service Helps Design Treatment Plans From Afar

Complex patients benefit from expert dosimetry teams

March 27, 2017/Cancer/Genomics

Rarely Studied Gene USF3 Plays Role in Predisposition to Thyroid Cancer

Study of a family with Cowden Syndrome, thyroid cancer

BackPage 89 of 91Next